O'Shaughnessy Asset Management’s Arbutus Biopharma ABUS Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-124,853	Closed	-$1.89M	–	1004
2014 Q4	$1.89M	Buy	124,853 +36,090	+41%	+$623K	0.04%	251
2014 Q3	$1.88M	Sell	88,763 -893	-1%	-$14.6K	0.03%	258
2014 Q2	$1.17M	Buy	89,656 +12,254	+16%	+$174K	0.02%	308
2014 Q1	$1.68M	Buy	+77,402	New	+$1.39M	0.03%	262

Other funds holding ABUS

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

O'Shaughnessy Asset Management's ABUS Position: Q1 2015 in Review

O'Shaughnessy Asset Management sold out of Arbutus Biopharma (ABUS) in Q1 2015, closing a stake of 124,853 shares — an estimated $1.89M sold.

O'Shaughnessy Asset Management first reported a position in ABUS in Q1 2014 and held it in 4 quarters. The position peaked at $1.89M in Q4 2014. 77 funds tracked by Wall St. Rank hold ABUS as of Q1 2015.

O'Shaughnessy Asset Management reported no remaining Arbutus Biopharma position as of Q1 2015 after selling out during the quarter.
O'Shaughnessy Asset Management sold 124,853 Arbutus Biopharma shares in Q1 2015, an estimated $1.89M.
O'Shaughnessy Asset Management first reported a position in Arbutus Biopharma in Q1 2014 and held it in 4 quarters.
O'Shaughnessy Asset Management's Arbutus Biopharma position peaked at $1.89M in Q4 2014.
77 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2015.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2015, filed 6 May 2015.